261 related articles for article (PubMed ID: 9242744)
21. Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging.
Outwater EK; Siegelman ES; Wilson KM; Mitchell DG
Radiology; 1996 Aug; 200(2):483-8. PubMed ID: 8685345
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
[TBL] [Abstract][Full Text] [Related]
23. High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters.
Tozaki M; Igarashi T; Matsushima S; Fukuda K
Radiat Med; 2005 Feb; 23(1):43-50. PubMed ID: 15786751
[TBL] [Abstract][Full Text] [Related]
24. MR imaging of the breast after surgery for breast cancer.
Whitehouse GH; Moore NR
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):591-603. PubMed ID: 7489311
[TBL] [Abstract][Full Text] [Related]
25. [MR imaging for breast cancer].
Seki T; Hachiya J; Nitatori T; Yokoyama K; Fukushima H; Uchigasaki S
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):347-56. PubMed ID: 8709936
[TBL] [Abstract][Full Text] [Related]
26. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
Ross MR; Schomer DF; Chappell P; Enzmann DR
AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
[TBL] [Abstract][Full Text] [Related]
27. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of phyllodes breast tumors from fibroadenomas on MRI.
Wurdinger S; Herzog AB; Fischer DR; Marx C; Raabe G; Schneider A; Kaiser WA
AJR Am J Roentgenol; 2005 Nov; 185(5):1317-21. PubMed ID: 16247156
[TBL] [Abstract][Full Text] [Related]
29. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
[TBL] [Abstract][Full Text] [Related]
30. MR imaging of the breast. Imaging and tissue characterization without intravenous contrast.
Santyr GE
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):673-90. PubMed ID: 7489316
[TBL] [Abstract][Full Text] [Related]
31. Magnetic resonance imaging of thymic epithelial tumors.
Kushihashi T; Fujisawa H; Munechika H
Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
33. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
35. Recurrent rectal cancer: diagnosis with dynamic MR imaging.
Müller-Schimpfle M; Brix G; Layer G; Schlag P; Engenhart R; Frohmuller S; Hess T; Zuna I; Semmler W; van Kaick G
Radiology; 1993 Dec; 189(3):881-9. PubMed ID: 8234720
[TBL] [Abstract][Full Text] [Related]
36. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations.
Kaiser WA; Zeitler E
Radiology; 1989 Mar; 170(3 Pt 1):681-6. PubMed ID: 2916021
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of optimized gadolinium-enhanced fast fluid-attenuated inversion recovery MR imaging in revealing lesions of the brain.
Melhem ER; Bert RJ; Walker RE
AJR Am J Roentgenol; 1998 Sep; 171(3):803-7. PubMed ID: 9725320
[TBL] [Abstract][Full Text] [Related]
38. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.
Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE
Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682
[TBL] [Abstract][Full Text] [Related]
39. Laser therapy for breast cancer: MR imaging and histopathologic correlation.
Mumtaz H; Hall-Craggs MA; Wotherspoon A; Paley M; Buonaccorsi G; Amin Z; Wilkinson I; Kissin MW; Davidson TI; Taylor I; Bown SG
Radiology; 1996 Sep; 200(3):651-8. PubMed ID: 8756910
[TBL] [Abstract][Full Text] [Related]
40. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation model.
Nunes LW; Schnall MD; Orel SG; Hochman MG; Langlotz CP; Reynolds CA; Torosian MH
Radiographics; 1999; 19(1):79-92. PubMed ID: 9925393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
